Skip to main content

6. Substance Abuse Disorders

This page is for educational purposes. Always verify with current clinical guidelines.

Learning Objectives

  • Apply DSM-5 criteria to diagnose substance use disorder and grade its severity
  • Recognize the clinical timeline and management of alcohol withdrawal and delirium tremens
  • Distinguish opioid intoxication from opioid withdrawal by signs, symptoms, and time course
  • Use the CAGE questionnaire to screen for alcohol use disorder in a clinical encounter
  • Compare pharmacological treatments across alcohol, opioid, and nicotine use disorders
  • Identify red flags that indicate a substance-related presentation is a medical emergency

Quick Answer

Substance use disorder (SUD) is a DSM-5 diagnosis describing a problematic pattern of substance use causing significant impairment or distress, confirmed by meeting at least 2 of 11 criteria within a 12-month period. It matters because SUDs are common (alcohol alone contributes to roughly 3 million deaths worldwide each year), frequently coexist with other psychiatric illness, and some withdrawal states — especially from alcohol and benzodiazepines — can kill a patient if unrecognized. For exams and clinical practice, the highest-yield material is the withdrawal timeline (alcohol withdrawal can progress to delirium tremens within 48–96 hours), the CAGE screening tool, and matching each substance to its specific treatment: benzodiazepines for alcohol withdrawal, buprenorphine or methadone for opioid use disorder, and naltrexone or acamprosate for relapse prevention in alcohol use disorder.

Overview

Substance use disorder is not simply "using drugs a lot." It is a specific, criteria-based diagnosis built around loss of control: the person keeps using despite consequences, needs more of the substance for the same effect (tolerance), and experiences physical or psychological symptoms when they stop (withdrawal). DSM-5 dropped the older DSM-IV split between "substance abuse" and "substance dependence" and replaced it with a single spectrum — substance use disorder — graded as mild, moderate, or severe based on how many of 11 criteria are met.

The clinical importance of this topic falls into two buckets. First, recognition: a screening tool like CAGE turns a vague suspicion into a structured conversation. Second, safety: some substances produce withdrawal syndromes that are genuinely dangerous. Alcohol and benzodiazepine withdrawal can cause seizures and death; opioid withdrawal is miserable but rarely lethal in an otherwise healthy adult. Knowing which is which changes how urgently you act.

Core Concepts

DSM-5 Diagnostic Criteria for Substance Use Disorder

Definition: A problematic pattern of substance use leading to clinically significant impairment or distress, manifested by at least 2 of 11 criteria within a 12-month period.

Explanation: The 11 criteria cluster into four groups: impaired control (using more than intended, unsuccessful efforts to cut down, spending excessive time obtaining/using/recovering, craving), social impairment (failure to fulfill role obligations, continued use despite social problems, giving up activities), risky use (physically hazardous use, continued use despite knowing it causes harm), and pharmacological criteria (tolerance, withdrawal). Severity is graded by criteria count: 2–3 = mild, 4–5 = moderate, 6+ = severe.

Example: A patient who needs increasing amounts of alcohol to feel the same buzz (tolerance) and gets shaky and anxious without a drink (withdrawal) already meets 2 criteria — mild alcohol use disorder — even before any social or occupational consequences appear.

Real-World Example: A resident evaluating a preoperative patient asks about alcohol use and finds the patient drinks a bottle of wine nightly, has tried to cut down twice without success, and continues despite their spouse's complaints. That's 3 criteria (unsuccessful cutting down, continued use despite interpersonal problems, plus likely tolerance) — moderate alcohol use disorder — which matters directly for anesthesia planning and withdrawal risk during admission.

Why It Matters: The criteria-based approach removes guesswork and moral judgment from diagnosis. It also directly predicts risk — a patient meeting criteria for tolerance and withdrawal needs a withdrawal management plan before any hospital admission, elective surgery, or forced abstinence.

Common Misunderstanding: Students often think you need "hard drug" use or visible social collapse to diagnose SUD. In reality, someone can meet full diagnostic criteria using only alcohol or prescription opioids while still holding a job and maintaining relationships — functional status does not rule out the diagnosis.

Alcohol Withdrawal and Delirium Tremens

Definition: Alcohol withdrawal is the constellation of symptoms that appears when a person with alcohol dependence abruptly reduces or stops drinking; delirium tremens (DTs) is its most severe, potentially fatal form.

Explanation: Chronic alcohol use enhances GABA (inhibitory) and suppresses glutamate (excitatory) neurotransmission, so the brain adapts by down-regulating GABA-A receptors and up-regulating NMDA glutamate receptors. When alcohol is suddenly withdrawn, this adapted brain is left in a state of unopposed excitation. Symptoms follow a predictable timeline:

  • 6–12 hours: tremor, anxiety, sweating, nausea, insomnia, mild autonomic hyperactivity
  • 12–24 hours: alcoholic hallucinosis — visual, auditory, or tactile hallucinations with intact orientation (patient knows the hallucinations aren't real)
  • 24–48 hours: withdrawal seizures — typically generalized tonic-clonic, single or brief flurry
  • 48–96 hours: delirium tremens — disorientation, severe autonomic instability (tachycardia, hypertension, fever), agitation, and vivid hallucinations with impaired reality testing. Untreated mortality historically approached 15–20%; with modern ICU-level care and benzodiazepines, mortality is closer to 1–5%.

Example: A patient admitted for a hip fracture who drank daily begins sweating and shaking on hospital day 2 (roughly 12–24 hours after their last drink) — classic early withdrawal, and a cue to start a symptom-triggered benzodiazepine protocol before it progresses.

Real-World Example: ICU teams use the CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol) scale to score withdrawal severity and titrate benzodiazepine dosing in real time, rather than giving a fixed dose regardless of symptoms.

Why It Matters: Delirium tremens is a true medical emergency. Missing early withdrawal signs in a hospitalized patient can allow progression to seizures or DTs, both of which carry real mortality risk — this is one of the few psychiatric presentations where a delay in treatment can be fatal within days.

Common Misunderstanding: Many students assume alcohol withdrawal seizures always occur before hallucinations or delirium. In fact the classic teaching order is tremor → hallucinosis → seizures → delirium tremens, but the timeline can overlap, and seizures can occasionally be the first sign in a patient whose earlier symptoms went unnoticed.

Opioid Use Disorder: Intoxication vs. Withdrawal

Definition: Opioid use disorder is a problematic pattern of opioid use meeting DSM-5 SUD criteria; opioid intoxication and opioid withdrawal are the two acute clinical states clinicians must distinguish at the bedside.

Explanation: Opioid intoxication presents with CNS depression: pinpoint (miotic) pupils, drowsiness or coma, respiratory depression, and hypotension — the classic triad is respiratory depression, pinpoint pupils, and decreased consciousness. Opioid withdrawal is essentially the physiologic opposite: dilated pupils, yawning, rhinorrhea, lacrimation, piloerection ("cold turkey" gooseflesh), muscle aches, abdominal cramping, diarrhea, and intense craving. Withdrawal typically begins 6–12 hours after the last dose for short-acting opioids (heroin) or 24–48 hours for long-acting opioids (methadone), peaks around 48–72 hours, and resolves over 7–10 days.

Example: A patient found unresponsive with a respiratory rate of 6/min and pinpoint pupils after taking oxycodone needs immediate naloxone — this is intoxication with life-threatening respiratory depression, not withdrawal.

Real-World Example: Emergency departments now commonly initiate buprenorphine for patients presenting in opioid withdrawal after an overdose reversal, using it as a bridge to outpatient medication-assisted treatment rather than simply discharging the patient once naloxone wears off.

Why It Matters: Unlike alcohol or benzodiazepine withdrawal, opioid withdrawal is rarely fatal on its own in a healthy adult — it feels like severe flu but doesn't typically cause seizures or death. This distinction changes urgency: opioid intoxication is the emergency requiring naloxone; opioid withdrawal is managed supportively and is a treatment opportunity, not a crisis.

Common Misunderstanding: Students often conflate opioid withdrawal with alcohol/benzodiazepine withdrawal and assume it is equally dangerous. It is not — the key life-threatening opioid emergency is overdose (respiratory depression), not withdrawal.

CAGE Questionnaire

Definition: A four-question screening tool for alcohol use disorder; the mnemonic stands for Cut down, Annoyed, Guilty, Eye-opener.

Explanation: The four questions are: (1) Have you ever felt you should Cut down on your drinking? (2) Have people Annoyed you by criticizing your drinking? (3) Have you ever felt Guilty about your drinking? (4) Have you ever had a drink first thing in the morning to steady your nerves or get rid of a hangover (Eye-opener)? Two or more "yes" answers is considered a positive screen warranting further evaluation; it is a screening tool, not a diagnostic instrument.

Example: A patient answers "yes" to feeling they should cut down and "yes" to needing a morning drink — a CAGE score of 2, positive screen, prompting a full history and DSM-5 criteria review.

Real-World Example: Primary care physicians incorporate CAGE into routine annual visits alongside other screening questionnaires (like PHQ-9 for depression) because brief screening catches alcohol use disorder that patients rarely volunteer unprompted.

Why It Matters: CAGE takes under a minute and has good sensitivity for detecting alcohol problems in primary care and preoperative settings, making early intervention possible before withdrawal, liver disease, or other complications develop.

Common Misunderstanding: A negative CAGE screen does not rule out alcohol use disorder, especially in patients who minimize use or in early-stage/high-functioning drinkers; CAGE is also less sensitive in women, adolescents, and binge drinkers who don't recognize a pattern.

Visual Learning

Real-World Applications

Substance use disorder knowledge is applied constantly outside the addiction clinic. Anesthesiologists screen for alcohol use before surgery because unrecognized dependence risks intraoperative or postoperative withdrawal. Emergency physicians must instantly distinguish opioid overdose (give naloxone) from other causes of altered mental status. Primary care physicians use brief screens like CAGE or AUDIT-C during routine visits because most people with SUD are never seen in a specialty addiction setting. Hospitalists managing any admitted patient with heavy alcohol use must proactively start withdrawal prophylaxis, because waiting for symptoms to appear before treating risks a preventable seizure or death on the ward.

Key Terms

TermDefinitionRelated Concept
Substance Use Disorder (SUD)DSM-5 diagnosis requiring 2+ of 11 criteria in 12 months, graded mild/moderate/severeTolerance, withdrawal, diagnostic criteria
ToleranceNeed for increasing amounts of a substance to achieve the same effectNeuroadaptation, dose escalation
WithdrawalSubstance-specific physiological and psychological symptoms on cessation or reduction of useDetoxification, dependence
Delirium Tremens (DTs)Severe alcohol withdrawal state with autonomic instability, disorientation, and hallucinations; can be fatalAlcohol withdrawal, CIWA-Ar
CIWA-ArClinical Institute Withdrawal Assessment for Alcohol; scored tool guiding symptom-triggered benzodiazepine dosingDelirium tremens, benzodiazepine taper
CAGE questionnaireFour-item alcohol screening tool (Cut down, Annoyed, Guilty, Eye-opener); score ≥2 is positiveScreening, AUDIT-C
Opioid intoxicationCNS depression triad: pinpoint pupils, respiratory depression, decreased consciousnessNaloxone, overdose
Opioid withdrawalFlu-like syndrome with dilated pupils, piloerection, cramping, and craving; rarely fatalBuprenorphine, methadone
NaltrexoneOpioid receptor antagonist used to prevent relapse in both opioid and alcohol use disorderRelapse prevention, MAT
BuprenorphinePartial opioid agonist used for opioid withdrawal management and maintenance therapyMedication-assisted treatment
DisulfiramMedication that blocks aldehyde dehydrogenase, causing an aversive reaction (flushing, nausea) if alcohol is consumedAlcohol use disorder treatment
AcamprosateMedication that reduces alcohol cravings by modulating glutamate/GABA balance during recoveryRelapse prevention
Motivational interviewingPatient-centered counseling technique that builds intrinsic motivation to change substance use behaviorBehavioral therapy, ambivalence

Common Mistakes

Misconception: "Substance abuse" and "substance dependence" are still separate DSM diagnoses, with abuse being the milder problem. Why it's wrong: DSM-5 (2013) eliminated the DSM-IV distinction between substance abuse and substance dependence entirely. This is a common source of confusion because older textbooks and some clinicians still use the outdated terms. Correct understanding: DSM-5 uses a single diagnosis, substance use disorder, on a severity spectrum (mild, moderate, severe) determined by the number of criteria met — there is no separate "abuse" category anymore.


Misconception: Opioid withdrawal is just as dangerous and potentially fatal as alcohol or benzodiazepine withdrawal. Why it's wrong: This mix-up is common because opioid withdrawal looks and feels dramatic (vomiting, diarrhea, severe muscle pain), but it does not cause the seizures or autonomic collapse that make alcohol/benzodiazepine withdrawal lethal. Correct understanding: Uncomplicated opioid withdrawal in an otherwise healthy adult is extremely unpleasant but not typically life-threatening; the true opioid emergency is overdose (respiratory depression), not withdrawal. Alcohol and benzodiazepine withdrawal are the classes that can independently kill a patient.


Misconception: A patient must be using illegal drugs or clearly failing at work/school to be diagnosed with a substance use disorder. Why it's wrong: This assumes visible social or occupational collapse is required for diagnosis, but DSM-5 criteria can be met purely through physiological signs (tolerance, withdrawal) or subtle behavioral patterns (unsuccessful attempts to cut down, craving) without any legal or occupational consequences. Correct understanding: A high-functioning professional who drinks heavily every night, has tried and failed to cut down, and needs more alcohol for the same effect meets DSM-5 criteria for alcohol use disorder regardless of job performance or legal status.

Comparison and Connections

FeatureAlcohol WithdrawalOpioid Withdrawal
Onset after last use6–24 hours6–12 hrs (short-acting) or 24–48 hrs (long-acting)
Pupil findingNot characteristicDilated (mydriasis)
Can cause seizuresYesNo
Can progress to deliriumYes (delirium tremens)No
Mortality risk if untreatedSignificant (historically 15-20%, now 1-5% with treatment)Very low in healthy adults
First-line treatmentBenzodiazepines (e.g., chlordiazepoxide, lorazepam)Buprenorphine or methadone
Relapse-prevention medicationNaltrexone, acamprosate, disulfiramNaltrexone, buprenorphine, methadone

Practice Questions

Recall

  1. What are the four questions in the CAGE questionnaire, and what score is considered positive? Guidance: Cut down, Annoyed, Guilty, Eye-opener. A score of 2 or more "yes" answers is a positive screen.

  2. How many DSM-5 criteria (out of 11) are required to diagnose substance use disorder, and how is severity graded? Guidance: At least 2 criteria within 12 months for diagnosis. 2-3 = mild, 4-5 = moderate, 6 or more = severe.

Understanding

  1. Explain why alcohol withdrawal can cause seizures and delirium tremens while opioid withdrawal typically does not. Guidance: Chronic alcohol use enhances GABA and suppresses glutamate signaling; the brain compensates by down-regulating inhibitory GABA-A receptors and up-regulating excitatory NMDA receptors. Sudden alcohol removal leaves the brain in a hyperexcitable state, producing seizures and delirium. Opioids act on opioid receptors and don't produce this same GABA/glutamate rebound, so withdrawal is uncomfortable but not seizure-inducing.

  2. Why did DSM-5 combine "substance abuse" and "substance dependence" into a single diagnosis? Guidance: Research showed the two categories weren't cleanly distinct clinically — many patients had features of both, and "abuse" as a single-symptom diagnosis had poor validity. A single dimensional severity scale (mild/moderate/severe) better reflects how substance problems actually present and progress.

Application

  1. A patient hospitalized for pneumonia who drinks a pint of vodka daily starts showing tremor and anxiety on hospital day 2. What is happening, and what should be done? Guidance: This is early alcohol withdrawal (6-24 hour window). Start a symptom-triggered benzodiazepine protocol (using CIWA-Ar scoring), monitor vital signs closely, and watch for progression to hallucinosis, seizures, or delirium tremens over the next 24-72 hours.

  2. A patient is found with pinpoint pupils, a respiratory rate of 6/min, and is unresponsive. Is this intoxication or withdrawal, and what is the immediate treatment? Guidance: This is opioid intoxication/overdose (classic triad: miosis, respiratory depression, decreased consciousness). Immediate treatment is naloxone, an opioid receptor antagonist, plus airway and respiratory support.

Analysis

  1. Compare the mechanisms and clinical goals of naltrexone versus buprenorphine in treating opioid use disorder. Guidance: Naltrexone is a full opioid antagonist — it blocks the receptor entirely, preventing any opioid effect, but requires the patient to already be fully detoxified since it can precipitate withdrawal if opioids are still on board. Buprenorphine is a partial agonist — it activates opioid receptors enough to prevent withdrawal and cravings while having a ceiling effect that limits euphoria and respiratory depression, making it useful for both withdrawal management and maintenance therapy without requiring full detox first.

  2. A medical student argues that because opioid withdrawal is "not dangerous," it doesn't need urgent medical attention. Evaluate this reasoning. Guidance: The reasoning conflates "not lethal" with "not urgent." While opioid withdrawal itself rarely causes death in healthy adults, it is a critical treatment opportunity — untreated withdrawal drives patients back to opioid use (with high overdose risk from reduced tolerance) and away from care. Evidence-based practice treats withdrawal promptly with buprenorphine or methadone specifically because delay increases relapse and overdose risk, even though the withdrawal syndrome itself isn't independently fatal.

FAQ

Q: What's the difference between substance use disorder, intoxication, and withdrawal? Substance use disorder is the chronic diagnostic pattern (built on DSM-5 criteria met over 12 months). Intoxication and withdrawal are acute clinical states: intoxication is the direct pharmacological effect of the substance currently in the body, while withdrawal is what happens when a dependent person's body reacts to the substance being removed. A person can experience intoxication or withdrawal without meeting full criteria for substance use disorder, though the two often coexist.

Q: Why is alcohol withdrawal potentially fatal but alcohol intoxication (in moderate amounts) usually isn't? It's about direction of brain chemistry, not amount. Intoxication adds a CNS depressant on top of normal brain activity — dangerous mainly at very high doses (respiratory depression, aspiration). Withdrawal removes that depressant from a brain that has adapted by ramping up excitatory signaling, leaving it unopposed and hyperexcitable — this rebound excitation is what causes seizures and delirium tremens.

Q: Do all patients with alcohol use disorder need inpatient detoxification? No. Mild-to-moderate cases without a history of seizures, DTs, or significant comorbidities can often be managed with outpatient tapering protocols and close follow-up. Inpatient detox is reserved for patients with a history of severe withdrawal, seizures, DTs, significant medical comorbidities, or lack of a safe support system at home.

Q: How is opioid use disorder treated differently now compared to older "abstinence-only" approaches? Modern practice strongly favors medication-assisted treatment (MAT) — buprenorphine, methadone, or naltrexone combined with counseling — over abstinence-only detox. Studies consistently show MAT reduces overdose deaths, retains patients in treatment longer, and lowers relapse rates compared to detox alone, which has a very high relapse rate partly because reduced tolerance after abstinence makes any subsequent use far more likely to be fatal.

Q: Can someone have a substance use disorder without physical dependence (tolerance/withdrawal)? Yes. DSM-5 only requires 2 of 11 criteria, and tolerance/withdrawal are just 2 of them. A person can meet the diagnosis through purely behavioral and social criteria — such as failing role obligations, giving up important activities, and continued use despite relationship problems — without ever showing classic physical dependence, particularly with substances like cannabis or stimulants.

Quick Revision

  • DSM-5 replaced "abuse" and "dependence" with one diagnosis: substance use disorder, graded mild (2-3 criteria), moderate (4-5), severe (6+) out of 11 total criteria in a 12-month period
  • CAGE = Cut down, Annoyed, Guilty, Eye-opener; score of 2+ is a positive alcohol screen
  • Alcohol withdrawal timeline: tremor/anxiety (6-12 hrs) → hallucinosis with intact reality testing (12-24 hrs) → seizures (24-48 hrs) → delirium tremens (48-96 hrs)
  • Delirium tremens is a medical emergency: disorientation, autonomic instability, hallucinations; treated with benzodiazepines, historically up to 15-20% mortality untreated
  • Opioid intoxication triad: pinpoint pupils, respiratory depression, decreased consciousness — treat with naloxone
  • Opioid withdrawal: dilated pupils, piloerection, cramping, diarrhea, craving — miserable but rarely fatal in healthy adults
  • Alcohol use disorder treatment: benzodiazepines for acute withdrawal; naltrexone, acamprosate, or disulfiram for relapse prevention
  • Opioid use disorder treatment: buprenorphine or methadone for withdrawal/maintenance; naltrexone once fully detoxified
  • Medication-assisted treatment (MAT) outperforms abstinence-only detox for opioid use disorder in reducing relapse and overdose deaths
  • Behavioral therapies (CBT, motivational interviewing, contingency management) are effective across all substance use disorders, not substance-specific
  • Globally, alcohol contributes to roughly 3 million deaths annually per WHO estimates, making it the highest-burden substance worldwide

Prerequisites: Basic neuropharmacology (GABA, glutamate, dopamine reward pathway), DSM-5 diagnostic framework, Mental Status Examination

Related Topics: Mood Disorders (common comorbidity with SUD), Anxiety Disorders, Psychiatric Emergencies, Delirium and Neurocognitive Disorders, Introduction to Psychiatry

Next Topics: Psychiatric Emergencies, Clinical Psychopharmacology, Personality Disorders, Evidence-Based Psychotherapy